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Pharmacokinetics, Interactions with
Macromolecules and Species
Differences in Metabolism of DEHP
by Phillip W. Albro,* Jean T. Corbett,* Joanna L.
Schroeder,* Sandra Jordan* and Hazel B. Matthews*
Therecent long-term carcinogenesis bioassay ofdi(2-ethylhexyl) phthalate (DEHP) in rats and
mice reported by the National Toxicology Program was the first such bioassay to implicate
DEHP as ahepatocarcinogen. Atthe levels ofDEHP fed (up to 1.2%ofthediet fortwoyears), the
livers ofthe rats would have been exposed to unhydrolyzed diester; this would not have been the
case at lower dosages. Extrapolation to lower dosages is therefore questionable. We do not have
sufficient pharmacokinetic data in mice to evaluate the dose relationships as yet. Rodents differ
conspicuously from primates in their manner of metabolizing DEHP, both in terms of the
demand made on the oxidation potential ofthe liver and in the chemical properties ofthe major
metabolites. The relevance ofthese differences must be determined before rodent species can be
considered models for the effects of DEHP in humans. Radioactivity from carbonyl-labeled
DEHP did not associate with purified protein, RNA or DNA from rat liver in vivo. Label from
2-ethyl-(1-14C)-hexyl-labeled DEHP or mono(2-ethylhexyl) phthalate (MEHP) did appear to
associate strongly with purified DNA, but label from free 14C-labeled 2-ethylhexanol did not. The
apparent binding from DEHP and MEHP was not exchangeable, but was not proven to be
covalent. This phenomenon needs additional study.
Introduction
The studies to be presented in this report were
undertaken in response to the recent announce-
ment by the National Toxicology Program (NTP)
that di(2-ethylhexyl) phthalate (DEHP), fed at high
levels in the diet to rats and mice fortwo years, was
a hepatocarcinogen. We wanted to know something
about the possible mechanism of carcinogenesis in
rodent liver and also to explore the relevance ofthe
extremely high doses used to produce it.
Materials and Methods
Dose Dependence of Distribution/
Elimination
The first study relates to the effect ofthe dosage-
ofDEHP on its metabolism, distribution and excre-
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tion. Preliminary experiments with both Sprague-
Dawley (CD) and Fischer344 ratsrevealed thatthe
maximum amount ofDEHPthatcould be given as a
single oral dose without significant excretion of
unabsorbed DEHP inthe feces was 200 mg/kg body
weight. Pharmacokinetic studies using 14C-labeled
DEHP at doses above this level would rapidly
become dominated byunabsorbed DEHP and could
not be directly compared to rates of elimination at
lower doses.
We chose to give DEHP by gavage in cottonseed
oil rather than incorporated into the solid diet for
several reasons. First, we wished to avoid the
problem ofdetermining the amount offood actually
eaten, and the problem of achieving a comparable
dose among replicates on an ad libitum schedule.
Second, we wished to avoid the possibility of con-
tamination of urine and feces with radioactivity
fromfood crumbs. Mostimportantly, doctoringfeed
with high levels of substances that can be smelled
alters feeding habits. Feed containing low levels of
DEHP is consumed over a shorter time interval
than food containing ahigh level ofDEHP. In order20
to have DEHP dosage be the dominant variable,
then, it was necessary to administer the compound
by gavage.
To lessen the discrepancy between the NTP bio-
assay feeding conditions and the present study, the
DEHP was given each day at 5P.M., shortly before
the beginning of the dark cycle. The rats usually
began feeding shortly thereafter, so absorption
occurred in the presence of the normal dietary
nutrients.
The first studyinvolved 36 male Fischer344 rats,
12 in each of three groups (A, B and C). The rats
received NIH 31 chow and water ad libitum. Feces
and urine were collected daily at 4:30 P.M. and
stored frozen. Group A rats received 1.8 mg of
[7-14C]-DEHP (carbonyl label) per kilogram body
weight per day. Group B received 18 mg/kg per
day, and group C received 180 mg/kg per day. All
received the same amount of radioactivity, with
different amounts ofnonradioactive DEHP diluent.
Rats received a total of 10 daily doses of DEHP.
Three rats from each group were sacrificed 1, 3,
10 or 12 days after receiving their first dose of
DEHP. Various tissues andfeces wereradioassayed
using a tissue oxidizer. Urine was radioassayed
directly in liquid scintillation fluid. The profiles of
radioactive metabolites in urine were determined
by HPLC as described previously (1). Lipid-soluble
metabolites were extracted from liver (2) and chro-
matographed in Florisil with 15% diethyl ether in
hexane. Unhydrolyzed DEHP was measured by
radio-TLC of the eluate from Florisil on silica gel
GF in hexane:diethyl ether:acetic acid, 120:30:1.5
(v/v).
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Absorption Thresholds
In a separate experiment rats and mice were, in
triplicate, given single oral doses of DEHP in cot-
tonseed oilrangingfrom 1.8mg/kgbodyweightto 1
g/kg. The animals were sacrificed 6 hr later, as this
was the time after dosing at which the maximum
concentration of 14C was found in the livers. The
livers were assayed for intact DEHP as described
above. The results of this experiment were com-
pared to the level of DEHP found in the livers of
rats fed a diet containing 1% DEHP until the level
reached a steady state (- 6 days).
Species Dependence
The distributions of DEHP-derived metabolites
inurineofFischer344rats, CDmice, Syriangolden
hamsters, and Hartley albino guinea pigs were
determined following single oral doses of DEHP in
cottonseed oil by techniques applied previously to
urine from CD rats (1, 3, 4,), African Green mon-
keys (5) and humans (6). In general, the distribu-
tions were independent ofdose up to the amount of
DEHP that caused intact 14C-DEHP to appear in
the feces.
Labeling of Macromolecules
In the last type of experiment to be reported
here, male Fischer 344 rats were fed diets contain-
ingeither0.01% or 1% DEHP, unlabeled, ad libtum
for 11 days. The rats were given a tracer dose of
labeled DEHP or one of its metabolites on day 1,
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FIGURE 1. Outline of purification procedures for protein and
RNA from rat liver. TCA = trichloroacetic acid.
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day 6 orday 10. Rats given labeled DEHP on either
day 1 or day 10 were sacrificed on day 11; those
given labeled DEHP on day 6 were sacrificed on
day 7 (24 hr later). Livers were homogenized, after
which protein, RNA and DNA (7) were isolated in
highly purified form. The purification procedures
are briefly diagrammed in Figures 1 and 2. The
fractions were tested for cross contamination by
spectrophotometric assays (7-9), after which they
were radioassayed, as were aliquots ofthe original
homogenate, by digestion in NCS and dispersion in
Aquasol.
Results and Discussion
Dose Effects
The cumulative excretion of 14C expressed as a
percentage ofthe cumulative dose is diagrammed in
Figure 3. After an "adaptation period" of about 4
days, excretion became quite independent of the
dose. On an absolute basis, rats in group C were
eliminating 14C at a rate 100 times that ofthe group
A rats. Up to a dose rate of 180 mg/kg per day,
then, there was no indication of even beginning to
saturate the overall elimination mechanism.
Looking more specifically at the liver, we saw
(Table 1) that the percentage of the dose of 14C
retained in the livers tended to decrease with time
and also with increasing dose. The mean rates of
dropoff in radioactivity after dosing was stopped
were not statistically significantly different in the
three groups. There was no evidence, then, for
accumulation in this organ.
Essentially the same observations applied to the
testes as were noted for liver (Table 2), except that
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FIGURE 3. Cumulative excretion of 14C i
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1.8, (El) 18, or (+) 180 mg of [7-14C
weight per day by gavage in cottonsee
days.
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Table 1. Percentage of "4C fed left in liver (average ofthree).
'4C left in liver, %
Day 1.8 mg/kg/day 18 mg/kg/day 180 mg/kg/day
1 0.64 ± 0.31 0.45 ± 0.16 0.25 ± 0.08
3 0.44 ± 0.27 0.35 ± 0.03 0.15 ± 0.01
10 0.13 ± 0.05 0.15 ± 0.01 0.12 ± 0.02
12 0.06 ± 0.01 0.04 ± 0.01 0.04 ± 0.01
10-12
% hr 0.93 ± 0.27 0.53 ± 0.07 0.62 ± 0.14
Table 2. Percentage of '4C fed left in testes (average of
three).a
14C left in testes, % (± SD)
Day 1.8 mg/kg/day 18 mg/kg/day 180 mg/kg/day
1 0.0142(0.0028) 0.0148(0.0065) 0.0094(0.0049)
3 0.0060(0.0017) 0.0065(0.0005) 0.0064(0.0020)
10 0.0020(0.0004) 0.0019(0.0010) 0.0015(0.0006)
12 0.0037(0.0008) 0.0025(0.0010) 0.0032(0.0005)
aANOVA;F, = 1.0159, p = 0.4169; FR = 31.30, p = 0.0005.
testes never reached as high concentrations of
DEHP metabolites as did liver.
Thestructuresoftheurinarymetabolites ofDEHP
that still retain aromaticity are shown in Table 3.
These compounds are grouped according to func-
tionality, or roughly according to the extent of
oxidative metabolism needed to produce them, in
Table 4. This table indicates that the only statisti-
cally significant effect of the dosage of DEHP on
metabolite distribution in rat urine was a slight
increase infree phthalic acid withincreasingDEHP
dosage. This probably reflects a high Km for mono-
(2-ethylhexyl) phthalate (MEHP) ofthe lipase that
produces phthalic acid. A previous study oflipases
and esterases in various rat tissues (10) indicated
thattheonlydetectableMEHP-hydrolase waslocated
in liver microsomes. It is also possible that this
enzyme was induced at high levels of DEHP, but
there is no direct evidence at the present time.
Absorption Threshold
As the size of a single oral dose of DEHP was
increased, a threshold was reached above which
there was a steady climb in the amount of unhy-
drolyzed DEHP reaching the liver of rats. This is
diagrammed for Fischer rats in Figure 4. Fischer
c lb 12 rats on a diet ofNIH 31 chow fortified with DEHP
by weight reached a steady-state level of intact
in urine and feces as a DEHP in their livers corresponding to the peak
]maDleHraspecrvngb(o) level predicted in Figure 4. That is, by keeping
d oil, for 10 successive track of the amount of feed eaten per day per kg
body weight, and treating the amount of DEHPALBRO ET AL.
Table 3. Structures of DEHP metabolites after treatment
with diazomethane.
0
I K
C-XO--CH2-CH-Rj II I
o R2
Metabolite R1 R2
I -CH2-CO2-CH3 -CH2-CH3
II -(CH2)3-CH3 -CO2-CH3
III -(CH2)2-CO2-CH3 -CH2-CH3
IV -(CH2)3-CH3 -CH2-CO2-CH3
V -(CH2)2-CO2-CH3 -CH2-CH3
VI -(CH2)2-CO-CH3 -CH2-CH3
VII -(CH2)3-CH3 -CH2-CH2OH
VIIIa -CH2-CHOH-CH2-CH3 -CH2-CH3
IX -(CH2)2-CHOH-CH3 -CH2-CH3
X -(CH2)3-CH20H -CH2-CH3
XIb -(CH2)3-CH3 -CH2-CH3
aAbsent in the rat.
bMono(2-ethylhexyl) phthalate.
thereby ingested as though it were a single dose,
the concentration of DEHP in liver predicted in
Figure 4 was in excellent agreement with what was
found on analysis (123 pug/g vs 121 Rug/g found).
Makingthe approximationthatratsconsume feed
to the extent of 10% of their body weight daily,
then intact DEHP will reach their livers whenever
its concentration exceeds 0.43% ofthe diet. Levels
above and below the threshold are therefore quali-
tatively different relative to what chemical com-
pounds reach the liver. However, it must be keptin
mind that when the diet contains more than about
0.5% DEHP, rats tend to reduce their food con-
sumption.
In contrast to the results seen in rats, we were
unable to detect an absorption threshold in either
CD-1 orC3B6F1 micefordosesupto 1 gofDEHP/kg
body weight. This may reflect the higher level of
DEHP-hydrolase in the intestines of mice than in
the intestines of rats (10).
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FIGURE 4. Level of intact DEHP in livers of male rats 6 hr
after a single oral dose of [7-14C]-DEHP in cottonseed oil.
Association with Macromolecules
Table 5 shows the amounts ofradioactivity asso-
ciated with liver homogenates, purified protein,
RNA and DNA when Fischer 344 rats were given a
tracer dose of 14C-DEHP or its primary hydrolysis
products. The rats had been eating NIH 31 chow
fortified with unlabeled DEHP (1% by weight) for 6
days to build up the pools ofmetabolites and inter-
mediates to a steady-state level; the 14C tracer was
given, and the rats sacrificed 24 hr later. When 100
,uCi of carbonyl-14C (7-14C) DEHP was given, no
detectable radioactivity was found associated with
purified macromolecules. However, when the 14C
was in the ethylhexyl moiety of DEHP (1'-14C), all
three classes of macromolecules became labeled. If
the [1'-14C]-DEHP was saponified to phthalic acid
plustwoequivalentsof[1'-'4C]-2-ethylhexanol before
administration, protein was still labeled, but no
detectable 14C became associated with DNA. If
[1'-14C]-MEHP was given, DNA was again labeled,
Table 4. Metabolite distribution as a function of dose of DEHP.
14C in urine, %
Dose, mg/kg Day -OH side chain Diacids MEHP+PA
1.8 1 33.1 66.5 0.4
3 35.0 64.5 0.5
10 40.0 58.9 1.1
18 1 38.7 61.0 0.3
3 38.3 61.3 0.4
10 36.1 62.8 1.1
180 1 38.1 61.0 0.9
3 35.5 61.4 3.1
10 36.1 57.1 6.8
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but not as efficiently as from [1'-14C]-DEHP. Pro-
tein was much less efficiently labeled from [1'-14C]-
MEHP than from [1'-14C]-DEHP.
Ifthe label associated with DNA was covalently
bound, which cannot be proven without isolation
andcharacterization oftheadduct(s), itwould appear
that C-1 (at least) of2-ethylhexanol is incorporated
intoDNAonlywhenesterifiedethylhexanolisgiven.
In any event, it seems clear that the phthalate
moiety ofDEHP is not bound to either DNA, RNA
orproteininratliverundertheseconditions. Chem-
ical analysis of the DNA isolated according to the
procedure described detected less than 0.1% RNA
and less than 0.01% protein.
Table 6 shows the decrease with time in the
amount ofradioactivity associated with macromole-
cules labeled from [1'-14C]-DEHP. The decrease
rate for protein was consistent with the average
turnover rate of protein in rat liver (11) and much
slower than would be expected for simple exchange
with the unlabeled DEHP from the diet. Labeling
of DNA was slightly higher for rats on the 1%
DEHP diet than forthose onthe 0.01% DEHPdiet,
but there is insufficient information on pool sizes
and turnover rates to speculate on this phenome-
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non. The decrease in labeling of DNA with time
was faster for rats on the 0.01% DEHP diet than
would be expected if the decrease was simply due
to normal DNA turnover. This suggests that some
sort ofrepairmechanismcouldbeinvolvedthat was
less effective at reducing DNA radioactivity in rats
on the 1% DEHP diet. However, much more infor-
mation would be needed to establish that repair
was occurring. At best, this experiment suggests
that further studies of the interaction of DEHP
with DNA might be worthwhile.
Species Differences in Metabolism
The data in Table 7 are collected from several
sources. Urine was collected at intervals after sin-
gle oral (species other than primates) or IV [Afri-
can GreenmonkeyTs (5) andhumanleukemiapatients
(6)] doses of [7 1 C]-DEHP. Urine containing 90%
of the total radioactivity excreted was pooled for
analysis. Table 7 represents the distributions of
radioactive metabolites in pools ofurine from three
animals except monkeys (two) and humans (two,
nonradioactive DEHP). Urine was hydrolyzed with
P-glucuronidase for the data in Table 7. A compari-
Table 5. "Bound" radioactivity in macromolecules.
Liver activity, DPM/ga
7-14C-DEHP 1'-14C-DEHP 1-14C 2-Et Hexol 1'-14C-MEHP
Homogenate 25918 200247 221600 16460
Protein 0 67805 45180 1331
RNA 0 63000 4350 1878
DNA 0 400 0 114
aMeasured 24 hr after single oral dose of (a) i00 ,uCi of carbonyl-labeled (7-'4C) DEHP, ethylhexyl-labeled (1'-'4C) DEHP, or
[1-14C]-2-ethylhexanol + unlabeled phthalic acid, or 50 ,uCi ofethylhexyl-labeled (1'-14C) mono-ethylhexyl phthalate (MEHP). In all
cases the rats had feed containing 1% unlabeled DEHP, and water available ad libitum. One gram-equivalent ofliver corresponds to
approximately 190 mg ofprotein, 13.5 mg of RNA and 4 mg of DNA.
Table 6. Association of radioactivity with macromolecules.
Time after [1'-'4C] - DEHP given
0.01% DEHP diet 1.0% DEHP diet
1 day 10 days 1 day 10 days
Liver activity, DPM/g
Total 161835 9102 200247 14980
In protein 41171 4500 67805 7832
In RNA 40040 4402 63000 7471
In DNA 310 134 400 293
Protein activity, DPM/g
Protein 230 25 340 42
As RNA 3337 358 5122 607
As DNA 77 33 100 73
Decrease/10 days, %
Protein 89.1 88.4
RNA 89.3 88.1
DNA 56.8 26.7Table 7. Distribution of phthalate metabolites.
Percentage of total metabolites
Metabolite Rat Mouse Guinea pig Green monkey Man Hamster
Residual DEHP - 0.5 2.2 0.3
MEHP Trace 18.6 71.2 28.9 18.3 4.5
I 17.2 16.8 2.4 0.1 13.0
II 2.0 1.0 0.4 1.8 0.1
III 1.2 0.4 0.5 0.3
IV 3.3 0.8 0.4 1.2 0.4
V 51.3 1.1 6.9 4.2 5.3 14.0
VI 2.6 14.9 1.1 5.9 12.1 10.2
VII 2.6 7.2 0.8 7.0 11.9 4.9
VIII 5.7 8.1
IX 13.3 12.3 3.4 38.2 36.2 32.7
X 0.6 2.2 1.3 0.1 0.1 1.9
A, B, C 4.1 8.1 6.2 7.6 4.9 6.1
Phthalic acid 1.8 12.4 5.4 0.1 0.1 9.5
son of extracts from unhydrolyzed and glucuro-
nidase-hydrolyzed portions ofurine gave the results
shown in Table 8. No conjugates other than glucu-
ronides have been detected in any of the species
tested; glycine, taurine and sulfate conjugates have
been sought and found absent, in contrast toresults
reported for substituted benzoic and phenylacetic
acid metabolites (12).
Most ofour investigations ofurinary metabolites
have involved rats. The metabolite distributions in
rats, examined over the past 8 years, have been
surprisingly reproducible and independent of fac-
tors such as dose ofDEHP and age ofanimal. Rats
do not excrete conjugates ofDEHPmetabolites, an
observation that has been confirmed in at least
three strains (5, 13). In contrast, each ofthe other
five species examined excretes glucuronide conju-
gates (Table 6). In most cases, conjugates are the
major urinary metabolites.
Whereas primates excrete predominately glu-
curonides of MEHP, whose formation does not
require oxidativemetabolism, and metabolites with
hydroxyl side chains which require only one round
ofoxidativemetabolism, ratsexcretepredominately
metabolites having carboxyl groups on the side
chain (metabolites I-V). These diacids require from
three to six oxidative steps for their formation.
Carrying oxidative metabolism all the way to the
highly water-soluble diacids may be necessary to
compensate, in rats, for not making glucuronides.
Ifformation ofhydroxyl side chains involves, by
analogy with fatty acid w-oxidation, a mixed func-
tion oxidase reaction as postulated earlier (3), one
would expect a net conversion of NAD(P)H to
NAD(P). The additional steps, from alcohol to alde-
hyde (or ketone) and from aldehyde to acid, as well
as the apparent a- and p-oxidations needed to pro-
duce metabolites I-III, would all be associated with
net conversion of NAD(P) to NAD(P)H. Thus the
Table 8. Forms ofexcretion products in urine.
Excretion products, %
Species Free Conjugated
Rata 100 0
Mouse, CD 36 64
Guinea pig 35 65
Green monkey 20 80
Man 20 80
Hamster 85 15
'Three strains
overall demand on the oxidation potential of the
liver when high doses ofDEHP are given would be
in opposite directions for rat and primate. To the
extent that metabolism of DEHP is involved in its
biological activity, then, one must question seri-
ously whether rats can be accepted as a model for
man.
Summary
The recent long-term carcinogenesis bioassay in
rats and mice as reported at this conference by the
NTP is the first suchbioassay to report carcinogen-
esis by DEHP. It is also the first such bioassay to
have involved a level of DEHP in the diet high
enough to exceed the absorption threshold for
unhydrolyzed DEHP. The livers of the rats in the
NTP study would have been exposed to moderate
levels ofintact diester, whereas at levels halfthose
tested or below this would not have occurred. This
qualitative difference makesanyattemptstoextrap-
olate the hepatocarcinogenesis observed in rats to
lower dosage levels questionable. We do not have
enough pharmacokinetic datafrom mice to evaluate
the dose relationships as yet.
While we were unable to obtain any evidence for
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covalent binding ofthe phthalate moiety of DEHP
to macromolecules in rat liver, and there was also
no apparent binding of radioactivity from [1'-14C]-
2-ethylhexanol to DNA in vivo, the labeled carbon
atomfromeitherdi-([1'-14C]-2-ethylhexyl)phthalate
or the corresponding monoester did appear to bind
to DNA in rat liver in vivo. The diester was a more
efficient labeling precursor than the monoester.
Disappearance of 4C from the labeled DNA had a
time course consistent with the operation ofarepair
mechanism. If so, repair was less effective when
there was a high level of DEHP in the diet. That
the apparent binding to DNA was truly covalent
has not been proven; however, itwas not exchange-
able.
We found no saturation ofDEHP metabolic path-
ways in rats over the 100-fold range of dosages
between 1.8 mgDEHP/kgbodyweight perday andi
180 mg/kg per day. There was no apparent reason
to suspect metabolic saturation in the biological
activity of high DEHP dosages. Levels ofmetabo-
lites in liver and testes fluctuated for about four
days on a regimen ofdaily dosing, then slowly but
smoothly declined. This hinted at the operation of
an adaptation mechanism, and argued against tis-
sue accumulation.
Rats were unique among six species (including
man) tested, in that they did not excrete glucuron-
ideconjugates ofDEHPmetabolitesinurine. Rodent
species in general carried oxidative metabolism of
DEHP much farther than did primates; the former
should experience a net decrease and the latter a
net increase in the ratio ofNAD(P) to NAD(P)H in
liver during exposure to high levels of DEHP.
Whereas the major metabolites of DEHP in rat
urine are diacids, the major metabolites in urine of
primates are glucuronides of hydroxyacids. These
species differences in the metabolism ofDEHP cast
doubts upon the validity ofusingrats as amodel for
the effects of DEHP in man.
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